Evidence map›Paper›PMID 23456771›Full record

ReviewCurrent neurology and neuroscience reports2013

Chronopharmacology of anti-convulsive therapy.

Sriram Ramgopal, Sigride Thome-Souza, Tobias Loddenkemper

Abstract readReview
In one paragraph

Review in Current neurology and neuroscience reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Biological rhythms and epilepsy treatment.Frontiers in neurology · 2023
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Cycles in epilepsy.Nature reviews. Neurology · 2021
    Review
  15. Review
  16. Article
  17. Seizure pathways change on circadian and slower timescales in individual patients with focal epilepsy.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sriram RamgopalDivision of Epilepsy and Clinical Neurophysiology, Harvard Medical School, and Department of Neurology, Children's Hospital Boston, Boston, MA 02115, USA.
Sigride Thome-Souza
Tobias Loddenkemper

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately one-third of patients with epilepsy continue to have seizures despite antiepileptic therapy. Many seizures occur in diurnal, sleep/wake, circadian, or even monthly patterns. The relationship between biomarkers and state changes is still being investigated, but early results suggest that some of these patterns may be related to endogenous circadian patterns whereas others may be related to wakefulness and sleep or both. Chronotherapy, the application of treatment at times of greatest seizure susceptibility, is a technique that may optimize seizure control in selected patients. It may be used in the form of differential dosing, as preparations designed to deliver sustained or pulsatile drug delivery or in the form of 'zeitgebers' that shift endogenous rhythms. Early trials in epilepsy suggest that chronopharmacology may provide improved seizure control compared with conventional treatment in some patients. The present article reviews chronopharmacology in the treatment of epilepsy as well as future treatment avenues.

Indexed as

Drug ChronotherapyAbnormalities, Drug-InducedAdultAnimalsAnticonvulsantsBiotransformationBody TemperatureChildCircadian RhythmDrug Delivery SystemsEpilepsyFood-Drug InteractionsGene Expression RegulationHumansHydrocortisoneIntestinal AbsorptionAnticonvulsantsHydrocortisoneMelatonin

Identifiers

PMID23456771
PMCPMC3607723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.